R&DIn order to accelerate the implementation of the innovation and R&D development strategy, as the top designer of scientific and technological innovation, Dongcheng Pharmaceutical Innovation Institute will lead the Group’s technological innovation and R&D, center on the core issues of the industrial technology innovation, strengthen the technological innovation and joint research, speed up the breakthrough in the major common technical difficulties in the industry, and enable all business sector of the Group to become industry leaders and technological pacesetters.
Dongcheng Pharmaceutical will deepen the resource integration, optimize the industrial structure, continuously improve the innovation capability and core competitiveness of the enterprise, aim at the goal of “Global Heparin Specialist, China’s Nuclide Drug Leader”, and advance towards growing into a pharmaceutical enterprise that is leading in the specialized domain and continues to create superior value.
